The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops
Open Access
- 30 November 2023
- Vol. 42 (7) , 1445-1453
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation (INV-000875)
This publication has 42 references indexed in Scilit:
- Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort studyThe Lancet Global Health, 2018
- Update on Campylobacter vaccine developmentHuman Vaccines & Immunotherapeutics, 2018
- A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonneiVaccine, 2018
- Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memoryScientific Reports, 2018
- Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi ChildrenPLOS Neglected Tropical Diseases, 2016
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control studyThe Lancet, 2016
- Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in BangladeshEBioMedicine, 2015
- Sequential Acquisition of T Cells and Antibodies to Nontyphoidal Salmonella in Malawian ChildrenThe Journal of Infectious Diseases, 2014
- Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in HumansInfection and Immunity, 2010
- Campylobacter, from obscurity to celebrityClinical Microbiology and Infection, 2004